Drug Database
Back to search

France· FR:60181231

VELETRI 1,5 mg, poudre et solvant pour solution pour perfusion

A epoprostenol product containing époprosténol sodique, registered in France by JANSSEN CILAG INTERNATIONAL NV. The same ATC class is registered in 14 of our 19 countries.

ATC B01AC09

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedVELETRI 1,5 mg, poudre et solvant pou…ATCB01AC09REGISTER NO.FR:60181231PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about époprosténol sodiqueAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Epoprostenol is registered in 14 of 19 countries.

Countries holding a registration under ATC B01AC09 (epoprostenol), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 7 of them publish a price we can compare per daily dose
Search epoprostenol products by name

Epoprostenol · ATC B01AC09

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ÉPOPROSTÉNOL SODIQUE
Manufacturer
JANSSEN CILAG INTERNATIONAL NV
Country
France (FR)
ATC code
B01AC09
ATC class
Epoprostenol
Defined daily dose
38 mcg, P
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400958576560
    1 flacon(s) de poudre en verre - 1 flacon(s) de solvant en polyéthylène basse densité (PEBD) de 100 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

402 interactions on record for epoprostenol.

Graded by severity as the source publishes them — 34 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check epoprostenol against other medicinesHow interaction checks work

Epoprostenol · interactions on record

402 records

  • 34 severe
  • 269 moderate
  • 4 minor
  • 95 info

Most severe, free to view

  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • DanaparoidB01AB09severe
  • TinzaparinB01AB10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Epoprostenol in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All epoprostenol products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Flolan
  • Belgium · Flolan, Veletri
  • Czechia · Flolan, Veletri
  • Germany · Veletri
  • Denmark · Flolan
  • Spain · Epoprostenol Normon, Epoprostenol Sun
  • United Kingdom (Northern Ireland) · Epoprostenol Mercury Pharmaceuticals Ltd, Epoprostenol Sodium Hexal
  • Greece · Veletri
  • Hungary · Veletri
  • Ireland · Flolan, Veletri
  • Italy · Caripul, Flolan
  • Luxembourg · Flolan, Veletri
  • Netherlands · Epoprostenol Sun, Epoprostenol Sun Pharmaceutical Industries Europe
  • Poland · Veletri
  • Portugal · Epoprostenol Normon, Veletri
  • Slovakia · Veletri

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/34472e2e-9a99-4e7a-b0d8-db6c5dc3661c
GET /v1/drugs/34472e2e-9a99-4e7a-b0d8-db6c5dc3661c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "60181231",
  "date_amm": "2013-12-20",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "ÉPOPROSTÉNOL SODIQUE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre et  solvant pour solution pour perfusion",
  "voies_administration": "intraveineuse;voie extracorporelle autre",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about epoprostenol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console